These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15165222)

  • 21. Etanercept combined with methotrexate for high-need psoriasis.
    Driessen RJ; van de Kerkhof PC; de Jong EM
    Br J Dermatol; 2008 Aug; 159(2):460-3. PubMed ID: 18547310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methotrexate use and monitoring in Switzerland and Denmark.
    Dam TN; Panizzon R; Jemec GB
    Dermatology; 2005; 210(3):253. PubMed ID: 15785063
    [No Abstract]   [Full Text] [Related]  

  • 23. Methotrexate treatment in 13 children with severe plaque psoriasis.
    Collin B; Vani A; Ogboli M; Moss C
    Clin Exp Dermatol; 2009 Apr; 34(3):295-8. PubMed ID: 19175782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Yellow nail pigmentation due to methotrexate.
    Malka N; Reichert S; Trechot P; Barbaud A; Schmutz JL
    Dermatology; 1998; 197(3):276. PubMed ID: 9867364
    [No Abstract]   [Full Text] [Related]  

  • 25. Methotrexate in psoriasis under real-world conditions: long-term efficacy and tolerability.
    West J; Ogston S; Palmer C; Fleming C; Dawe R; Kumar V; Waterston S; Foerster J
    Br J Dermatol; 2016 Jun; 174(6):1407-10. PubMed ID: 26852010
    [No Abstract]   [Full Text] [Related]  

  • 26. Methotrexate: new therapeutic approaches.
    Puig L
    Actas Dermosifiliogr; 2014; 105(6):583-9. PubMed ID: 23434058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Patient education. Information letter on treatment of psoriasis with methotrexate].
    Groupe de recherche sur psoriasis de Société française de dermatologie, mai 2011
    Ann Dermatol Venereol; 2011 Dec; 138(12):861-2. PubMed ID: 22137631
    [No Abstract]   [Full Text] [Related]  

  • 28. The treatment of psoriasis vulgaris: 1% topical methotrexate gel.
    Eskicirak B; Zemheri E; Cerkezoglu A
    Int J Dermatol; 2006 Aug; 45(8):965-9. PubMed ID: 16911386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical psoriasis therapies and unmet patient needs: the importance of optimizing methotrexate.
    Greenberg R
    Cutis; 2016 Jan; 97(1):55-6. PubMed ID: 26919356
    [No Abstract]   [Full Text] [Related]  

  • 30. [The practice guideline 'Photo(chemo)therapy and systemic therapy in severe chronic plaque-psoriasis'].
    Spuls PI; Tuut MK; van Everdingen JJ; de Rie MA;
    Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2121-5. PubMed ID: 15553355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complete reversion of anti-infliximab immunization by methotrexate combination in a patient with psoriasis.
    Vincent T; Best M; Plawecki M; Girard C
    J Dermatol; 2015 Oct; 42(10):1030-1. PubMed ID: 26119228
    [No Abstract]   [Full Text] [Related]  

  • 32. Briakinumab versus Methotrexate for Psoriasis.
    Wu JJ
    N Engl J Med; 2012 Jan; 366(4):379-80; author reply 380. PubMed ID: 22276833
    [No Abstract]   [Full Text] [Related]  

  • 33. Briakinumab versus methotrexate for psoriasis.
    Malgarini RB; Pimpinella G
    N Engl J Med; 2012 Jan; 366(4):379; author reply 380. PubMed ID: 22276832
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of the effectiveness of childhood generalized pustular psoriasis treatment in 30 cases.
    Juanqin G; Zhiqiang C; Zijia H
    Pediatr Dermatol; 1998; 15(2):144-6. PubMed ID: 9572705
    [No Abstract]   [Full Text] [Related]  

  • 35. How are we using systemic drugs to treat psoriasis in children? An insight into current clinical U.K. practice.
    Burden-Teh E; Lam ML; Taibjee SM; Taylor A; Webster S; Dolman S; Jury C; Caruana D; Darne S; Carmichael A; Natarajan S; McPherson T; Moore A; Katugampola R; Kalavala M; Al-Ismail D; Richards L; Jones V; Batul Syed S; Glover M; Hughes J; Anderson E; Hughes B; Helbling I; Murphy R
    Br J Dermatol; 2015 Aug; 173(2):614-8. PubMed ID: 25601323
    [No Abstract]   [Full Text] [Related]  

  • 36. Response to the letter to editor re: "Methotrexate and psoriasis: consensus conference".
    Menter A
    J Am Acad Dermatol; 2012 Apr; 66(4):689; author reply 689-90. PubMed ID: 22421115
    [No Abstract]   [Full Text] [Related]  

  • 37. Psoriasis of the lips: an unusual localization.
    Gül U; Kiliç A; Gönül M; Soylu S; Bilgili S; Han O
    Int J Dermatol; 2006 Nov; 45(11):1381-2. PubMed ID: 17076738
    [No Abstract]   [Full Text] [Related]  

  • 38. Systemic methotrexate for the treatment of psoriasis.
    Yélamos O; Puig L
    Expert Rev Clin Immunol; 2015 May; 11(5):553-63. PubMed ID: 25779551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic and light therapies for the management of childhood psoriasis: part II.
    Cordoro KM
    Skin Therapy Lett; 2008 May; 13(4):1-3. PubMed ID: 18648714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclosporine in childhood psoriasis.
    Mahé E; Bodemer C; Pruszkowski A; Teillac-Hamel D; de Prost Y
    Arch Dermatol; 2001 Nov; 137(11):1532-3. PubMed ID: 11708969
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.